ANTEGREN(R) (Natalizumab) Clinical Study Results Published in New England Journal of Medicine Show Promising Data on Disease Remission and Quality Of Life for Patients With Crohn's Disease.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Source:
    PR Newswire. 2003.